Exploring Ferroptosis Biology
The Henry lab focuses on ferroptosis, an iron-dependent form of cell death, and its profound implications in normal physiology and pathological conditions such as cancer and liver disease. We employ an integrative approach in our research. This includes functional genomic screens, metabolomics, bioengineering, and biochemical methodologies, as well as a range of in vitro and in vivo models. We are committed to pushing the boundaries of knowledge in this domain, fostering interdisciplinary collaborations, and translating our discoveries to inform new therapies.
Featured News
-
Wed, Oct 01, 2025
The Henry lab is excited to officially join the HHMI community! Dr Whitney Henry begins her appointment today as a 2025 HHMI Freeman Hrabowski Scholar.
https://www.hhmi.org/programs/freeman-hrabowski-scholars/2025-scholars -
Tue, Jul 1, 2025
Dr Henry has been appointed the Robert A. Swanson (1969) Career Development Professor of Life Sciences at MIT. This three-year professorship honors junior faculty who show exceptional promise in advancing life sciences research and education. -
Mon, Apr 8, 2024
Kandice Levental and Whitney Henry coauthored an article titled “Lipidomes define immune cell identity” discussing a study which showed that cell-specific lipid compositions determine a key functional phenotype: their susceptibility to ferroptosis. -
Mon, Dec 4, 2023
Whitney Henry receives a grant from the Emerald Foundation, Inc. for groundbreaking cancer research. This funding marks the first installment of a three-year commitment to support the lab's pioneering project, Ferroptosis and the Tumor Immune Microenvironment.